Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sharon S Choi"'
Autor:
Sudipta Mohanty, Patrick Looser, Bibhu D Mohanty, Martin E. Goldman, Valentin Fuster, Jonathan L. Halperin, Rishi Handa, Sharon S Choi, Lakshmi R Gokanapudy
Publikováno v:
Vascular Medicine. 19:190-204
Increasing use of the new oral anticoagulants (NOACs) – dabigatran, rivaroxaban, and apixaban – has prompted considerable discussion in the medical community even as warfarin remains the mainstay of therapy. This article raises 10 controversial i
Autor:
Evan Lyon, Mary C. Smith Fawzi, Patrice Nevil, Paul Farmer, Darius Jazayeri, Hamish S. F. Fraser, Joia S. Mukherjee, Yusuf Karacaoglu, Sharon S Choi, Fernet Leandre
Publikováno v:
BMJ. 329:1142-1146
Lack of infrastructure, including information and communication systems, is considered a barrier to successful HIV treatment programmes in resource poor areas. The authors describe how they set up a web based medical record system linking remote area
Autor:
Sharon S Choi
Publikováno v:
Expert review of cardiovascular therapy. 12(12)
Atherosclerotic renovascular disease is the most common cause of secondary hypertension. The patients with renovascular disease are at increased risk for adverse cardiac outcomes. Recent trials comparing medical therapy alone to medical therapy with
Autor:
Bibhu D, Mohanty, Patrick M, Looser, Lakshmi R, Gokanapudy, Rishi, Handa, Sudipta, Mohanty, Sharon S, Choi, Martin E, Goldman, Valentin, Fuster, Jonathan L, Halperin
Publikováno v:
Vascular medicine (London, England). 19(3)
Increasing use of the new oral anticoagulants (NOACs) - dabigatran, rivaroxaban, and apixaban - has prompted considerable discussion in the medical community even as warfarin remains the mainstay of therapy. This article raises 10 controversial issue
Autor:
Hamish S F, Fraser, Ali, Habib, Mark, Goodrich, David, Thomas, Joaquin A, Blaya, Joseph Reginald, Fils-Aime, Darius, Jazayeri, Michael, Seaton, Aamir J, Khan, Sharon S, Choi, Foster, Kerrison, Dennis, Falzon, Mercedes C, Becerra
Publikováno v:
Studies in health technology and informatics. 192
Multi-drug resistant TB (MDR-TB) is a complex infectious disease that is a growing threat to global health. It requires lengthy treatment with multiple drugs and specialized laboratory testing. To effectively scale up treatment to thousands of patien
Publikováno v:
Current opinion in cardiology. 27(6)
Purpose of review To describe the hazard of in-hospital major bleeding after acute coronary syndromes. Recent findings Long-term complications of early bleeding can extend to over 3 years beyond the index event. Nonaccess-site bleeding accounts for m
Autor:
Katiuska Chalco, Rocío M. Hurtado, Keith Joseph, Epifanio Sánchez, Karim Llaro, Mercedes C. Becerra, Joia S. Mukherjee, Jennifer Furin, Sidney Atwood, Garrett M. Fitzmaurice, Sharon S Choi, Lorena Mestanza, Carole D. Mitnick, Sasha C. Appleton, Felix A. Alcantara Viru, Dalia Guerra, Molly F. Franke, Michael Rich, Alexander Sloutsky, Hamish S. F. Fraser, Sonya Shin, Jaime Bayona, Darius Jazayeri, Maribel Muñoz, Cesar Bonilla, Eda Palacios, Kwonjune J. Seung
Background Extensively drug-resistant tuberculosis has been reported in 45 countries, including countries with limited resources and a high burden of tuberculosis. We describe the management of extensively drug-resistant tuberculosis and treatment ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7500e7f3fa565f928379630c313a85a9
https://europepmc.org/articles/PMC2673722/
https://europepmc.org/articles/PMC2673722/
Publikováno v:
AMIA ... Annual Symposium proceedings. AMIA Symposium.
Publikováno v:
AMIA ... Annual Symposium proceedings. AMIA Symposium.
The PIH-EMR is a Web based electronic medical record that has been in operation for over four years in Peru supporting the treatment of drug resistant TB. We describe here the types of evaluations that have been performed on the EMR to assess its imp
Publikováno v:
AMIA ... Annual Symposium proceedings. AMIA Symposium.
Large healthcare projects in developing countries need to track data for clinical care, patient outcomes, medication supplies, and research. These heterogeneous information needs are compounded by the wide range of skills and experience of staff. We